Advertisement

Klinisch-therapeutische Aspekte der experimentellen Adjuvansarthritis

  • Klaus L. Schmidt
Conference paper
Part of the Der Rheumatismus book series (2798, volume 45)

Zusammenfassung

Anläßlich der Hauptsitzung Nr. 34 („Animal Models“) im Rahmen des VII. Europäischen Rheumatologenkongresses in Brighton 1971 stellte M.W. Whitehouse folgende Forderungen an ein „gutes“ Modell auf: 1. Chronizität, 2. einen gut meßbaren Schaden am normalen Gewebe oder an den Gewebsfunktionen, 3. eine leichte Untersuchungs- möglichkeit an großen Zahlen kleiner Tiere.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ackerman NR (1979) Effects of Naproxen on connective tissue changes in the adjuvant arthritic rats. Arthr Rheum 22:1365CrossRefGoogle Scholar
  2. 2.
    Arinoviche R, Loewi G (1970) Effect of two cytotoxic drugs and of antilymphocytic serum on immune-and non-immune inflammation in experimental aminals. Ann rheumatic Dis 29:32CrossRefGoogle Scholar
  3. 3.
    Armkraut AA, Solomon GF, Kramer HC (1971) Stress, early experience and adjuvant-induced arthritis in the rat. Psychosom Med 33:203Google Scholar
  4. 4.
    Arumagham R, Bose SM (1980) Influence of prostaglandins El and E2 on collagen metabolism in adjuvant-induced arthritis. Prostaglandins Med 4:341CrossRefGoogle Scholar
  5. 5.
    Arumagham R, Bose SM (1981) Effect of indomethacin and naproxen on the metabolism of collagen in adjuvant-induced arthritis. Scand J Rheumatol 10:161CrossRefGoogle Scholar
  6. 6.
    Aspinall RL, Cammarata PS (1969) Effect of prostaglandin E2 on adjuvant arthritis. Nature 224:1320PubMedCrossRefGoogle Scholar
  7. 7.
    Barbier A, Brélière JC, Ronucci R (1985) Activity of SR 41319 on rat adjuvant arthritis: Influence of the treatment schedule. XVI. Int. Congres of Rheumatol. Sydney, Abstr. P 508, p 319Google Scholar
  8. 8.
    Battisto JR, Smith RN, Beckman K, Sternlicht M, Welles WL (1984) Susceptibility to adjuvant arthritis in DA and F344 rats. A dominant trait controlled by an autosomal gene locus linked to the major histocompatibility complex. Arthritis Rheum 25:1194Google Scholar
  9. 9.
    Baumgartner R, Obenaus H, Stoerk HC (1974) Suppression of adjuvant arthritis by penicil-lamine in pyridoxine-deficient rats. Proc Soc Exp Biol Med 146:241PubMedGoogle Scholar
  10. 10.
    Baumgartner WA, Leeb JE, Hill VA, Lorber A (1974) Restorative action of gold sodium thiomalate (gst) on abnormal mitochondrial function in adjuvant arthritis. Arthritis Rheum 16:534Google Scholar
  11. 11.
    Baumstieger P, Pohl J (1973) Über Veränderungen des Blutserums und lymphatischen Systems bei der Adjuvanskrankheit der Ratte in Abhängigkeit vom Alter. Inaugural-Diss., GießenGoogle Scholar
  12. 12.
    Beck FJW, Whitehouse MW (1974) Drug sensitivity of rat adjuvant arthritis, induced with adjuvants containing no mineral oil components. Proc Soc Exp Biol Med 146:665PubMedGoogle Scholar
  13. 13.
    Bekemeier H, Hirschmann R, Giessler AJ (1975) Peroxidaseaktivität in der Pfote bei Ad-juvansarthritis und ihre Beeinflussung durch Antiphlogistika in vitro. Z Rheumatol 34:71PubMedGoogle Scholar
  14. 14.
    Benslay DN, Nickander R (1982) Radiologic studies of the effect of benoxaprofen on bone damage in the adjuvant arthritic rat. Eur J Rheumatol Inflamm 5:175PubMedGoogle Scholar
  15. 15.
    Best R, Spencer PSJ (1968) The effect of alloxan diabetes upon adjuvant induced arthritis in the rat. J Pharm Pharmacol 20:126CrossRefGoogle Scholar
  16. 16.
    Binderup L, Bramm E, Arrigoni-Martelli E (1980) Immunological effects of D-penicillamine during experimentally induced inflammation in rats. Scand J Immunol 12:239PubMedCrossRefGoogle Scholar
  17. 17.
    Binderup L, Bramm E, Arrigoni-Martelli E (1978) Characterization of inhibitor(s) of lymphocyte activation in serum from rats with adjuvant arthritis. Pharmacology 17:288PubMedCrossRefGoogle Scholar
  18. 18.
    Binderup L, Bramm E, Arrigoni-Martelli E (1980) Effect of D-penicillamine in vitro and in vivo on macrophage phagocytosis. Biochem Pharmacol 29:2273PubMedCrossRefGoogle Scholar
  19. 19.
    Bobalik GR, Aldred JP, Kleszynski RR, Stubbs RK, Zeedyk RA, Bastian JW (1974) Effects of salmon calcitonin and combination drug therapy on rat adjuvant arthritis. Agents Actions 4/ 5:364CrossRefGoogle Scholar
  20. 20.
    Bolosiu HD, Gligore V (1974) Does mefenamic acid cure or prevent adjuvant experimental arthritis in rats? J Int Med Res 2:156Google Scholar
  21. 21.
    Bombara G, Morabito D, Puglisi N et al. (1973) Effetti della timectomia neonatale sulla poli-artrite experimentale da adiuvante di Freund nel ratto albino. Quad Sclavo Clin Lab 9:636 (Zit. n. Exc Med Arthritis Rheum)Google Scholar
  22. 22.
    Bonta JL, Parnham MJ, van Vliet L (1978) Combination of theophylline and prostaglandin E1 as inhibitors of the adjuvant-induced arthritis syndrome of rats. Ann Rheum Dis 37:212PubMedCrossRefGoogle Scholar
  23. 23.
    Burchard M, Horstmann I (1975) Zur Wirkung kurzdauernder täglicher Wärmeapplikationen auf die lymphatischen Organe bei der Adjuvans-Arthritis der Ratte. In augural-Diss., GießenGoogle Scholar
  24. 24.
    Burns AB, Persellin RH (1971) Experimental penile corporal (auto-immune?) vasculitis in the rat. Invest Urol 9:241PubMedGoogle Scholar
  25. 25.
    Butler M, Giannina T, Cargill Tisteinetz BG (1969) Abnormal sulfhydril-disulfide interchange in serum of rats with adjuvant-arthritis: Correction by antiinflammatory agents. Proc Soc Exp Biol Med 132:484Google Scholar
  26. 26.
    Cashin CJ, Dawson W, Kitchen A (1977) The pharmacology of benoxaprofen (2(4-chloro-phenyl) alpha methyl 5 benzoxazole acetic acid), LRCL 3794, a new compound with anti-inflammatory activity apparently unrelated to inhibition of prostaglandin synthesis. J Pharm Pharmacol 29:330PubMedCrossRefGoogle Scholar
  27. 27.
    Cawthorne MA, Palmer ED, Green J (1976) Adjuvant-induced arthritis and drug metabolizing enzymes. Biochem Pharmacol 25:2683PubMedCrossRefGoogle Scholar
  28. 28.
    Chandra C, Gupta SS (1972) Anti-inflammatory and antiarthritic activity of volatile oil of Curcuma longa (Haldi). Indian J Med Res 60:138PubMedGoogle Scholar
  29. 29.
    Chang YH (1977) Adjuvant polyarthritis. II. Suppression by tilorone. Pharmacol Exp Ther 203:156Google Scholar
  30. 30.
    Chang YH, Bluestone R (1981) Adjuvant polyarthritis. VI. Effect of oxonate-induced hy-peruricemia on the development of acute inflammation, immune response and adjuvant arthritis. Pharmacol Exp Ther 219:731Google Scholar
  31. 31.
    Chatfield DH, Cashin CH, Kitchen EA, Green JN (1977) Relation between plasma concentration and therapeutic efficacy of a new antiinflammatory compound, benoxaprofen (LRCL 3794) in rats with adjuvant induced arthritis. J Pharm Pharmacol 29:372CrossRefGoogle Scholar
  32. 32.
    Colombo C, Steele RE, Lestham JH, Steinetz BG (1979) An emphysema like reaction in lungs of adjuvant arthritic rats. Proc Soc Exp Biol Med 161:225PubMedGoogle Scholar
  33. 33.
    Corbin LA, Forst MB, Rand SA, Davis RH (1979) Effect of xanthurenic acid and indole acetic acid on peritoneal fluid content of adjuvant arthritic rats. IRCS Med Sci 7:128Google Scholar
  34. 34.
    Courtright LJ, Kuzell WC (1965) Sparing effect of neurological deficit and trauma on the course of adjuvant arthritis in the rat. Ann Rheum Dis 24:360PubMedCrossRefGoogle Scholar
  35. 35.
    Currey HLF, Ziff M (1966) Suppression of experimentally induced polyarthritis in the rat by heterologous antilymphocyte serum. Lancet II: 889Google Scholar
  36. 36.
    Currey HLF (1970) Adjuvant arthritis in the rat. Effect of intraperitoneal injections of either whole dead mycobacteria or tuberkulin. Ann Rheum Dis 29:314PubMedCrossRefGoogle Scholar
  37. 37.
    Dabrowski M (1970) The role of thymus in the immunological response of the draining lymph node in rats with adjuvant induced polyarthritis. III. Autoradiographic studies of lymph cells. Rheumatologia 8:239 (Zit. n. Exc Med Arthritis Rheum)Google Scholar
  38. 38.
    Dabrowski M, Korsakowska M, Ryzewska A (1971) Immunosuppressive action of in-dometacin on the course of adjuvant induced polyarthritis in rats, (poln.) Rheumatologia 9:217 (Zit. n. Exc Med Arthritis Rheuma)Google Scholar
  39. 39.
    Dabrowski M, Korsakowska M, Ryzewska A (1971) Evaluation of the immunosuppressive action of isopropylaminophenazone on adjuvant-induced polyarthritis (poln.) Reumatologia 9:379 (Zit. n. Exc Med Arthritis Rheum)Google Scholar
  40. 40.
    DiPasquale G, Elaj P, Rassaert CL (1974) Polonged pentobarbital sleeping time in adjuvant induced polyarthritis. Res Commun Chem Pathol Pharmacol 9:253PubMedGoogle Scholar
  41. 41.
    DiPasquale G, Massaert C, Welaj P, Gingold J (1975) Effect of single and multiple treatment with phenylbutazone in normal and adjuvant induced polyarthritis in rats. Agents Actions 5:52PubMedCrossRefGoogle Scholar
  42. 42.
    Duane SR (1977) Alteration of hepatic microsomal enzyme systems and the lethal action of nonsteroidal anti arthritic drugs in acute and chronic models of inflammation. Agents Actions 7:289CrossRefGoogle Scholar
  43. 43.
    Eckl HJ (1982) Zur Wirkung natürlicher Sole-und Kohlensäure-Solethermen auf experimentelle Entzündungen. Inaugural-Diss. GießenGoogle Scholar
  44. 44.
    Eighteenth Rheumatism Review (1968) Arthritis Rheum [Suppl 3] 11:665Google Scholar
  45. 45.
    Elliott PNC, Bolam JP, Ford Hutchinson AW, Smith MJH (1974) The effects of a human plasma fraction on adjuvant arthritis and granuloma pellet reaction in the rat. J Pharm Pharmacol 26:751PubMedCrossRefGoogle Scholar
  46. 46.
    Fantini F, Cattaneo R, Invernizzi F (1965) Effetti d’indomethacin sulla artrite da adiuvante del ratto. Reumatismo 17:163PubMedGoogle Scholar
  47. 47.
    Flora L (1979) Comparative antiinflammatory and bone protective effects of two di-phosphonates in adjuvant arthritis. Arthritis Rheum 22:340PubMedCrossRefGoogle Scholar
  48. 48.
    Francis MD, Flora L, King WR (1972) The effects of disodium ethane 1 hydroxy 1.1 diphosphonate on adjuvant induced arthritis in rats. Calcif Tissue Res 9:109PubMedCrossRefGoogle Scholar
  49. 49.
    Francis M-D, Horn PA, McCreary LD (1983) Penetration and effect of topically applied dimethylsulfoxide or indometacin on adjuvant arthritis in the rat. Arthritis Rheum 26:861PubMedCrossRefGoogle Scholar
  50. 50.
    Franke A, Eckhardt D, Keitel W (1975) Parabioseversuche bei Adjuvans-Arthritis (vorläufige Ergebnisse). Allerg Immunol (Leipz) 21:103Google Scholar
  51. 51.
    Glenn EM (1966) Adjuvant-induced arthritis: Effects of certain drugs in incidence, clinical severity and biochemical changes. Am J Vet Res 27:339PubMedGoogle Scholar
  52. 52.
    Glenn EM (1968) Inhibition of adjuvant induced polyarthritis with cytarabine. Proc Soc Exp Biol Med 129:960Google Scholar
  53. 53.
    Gorog P, Kovacs JB (1972) Inhibitory effect of phenformin in adjuvant arthritis on the rat. Pharmacology 7:96PubMedCrossRefGoogle Scholar
  54. 54.
    Gorog P, Kovacs IB (1975) Antiarthritic and antithrombotic effects of topically applied dimethylsulfoxide, Ann NY Acad Sci 243:91PubMedCrossRefGoogle Scholar
  55. 55.
    Graeme ML, Fabry E, Sigg EB (1966) Mycobacterial adjuvant periarthritis in rodents and its modification by antiinflammatory agents. J Pharmacol Exp Ther 153:373Google Scholar
  56. 56.
    Gralla EJ, Wiseman EH (1968) The adjuvant arthritic rat: inflammatory parameters during development and regression of gross lesions. Proc Soc Exp Biol Med 128:493PubMedGoogle Scholar
  57. 57.
    Grant NH, Rosenthal ME, Alburn HE, Singer AC (1971) Slowed enzyme release and its normalization by drugs in adjuvant induced polyarthritis. Biochem Pharmacol 20:2821PubMedCrossRefGoogle Scholar
  58. 58.
    Grimova J, Adam M (1971) Vliv complexu tezkych kovu na adjuvantni nemoc. Fysiatr Reumatol Vestn 49:64 (Zit. n. Exc Med Arthritis Rheum)Google Scholar
  59. 59.
    Haskard DO, Currey HLF (1984) Gold exacerbates adjuvant arthritis in the rat. Ann Rheum Dis 43:350PubMedCrossRefGoogle Scholar
  60. 60.
    Heilman WP, Heilman RD, Scozzi JA (1980) Synthesis and antiinflammatory evaluation of 3-methylthio-l,2,4-triazines, 3-alkoxy-l,2,4-triazines, and 3-aryloxy-l,2,4-triazines. J Pharm Sci 69:282PubMedCrossRefGoogle Scholar
  61. 61.
    Henson EC, Brunson JG (1970) Studies of adjuvant-induced arthritis in the albino rat (CNF strain). Ann Rheum Dis 29:185PubMedCrossRefGoogle Scholar
  62. 62.
    Hirschelmann R, Bekemeier H, Stelzner A (1977) Acute-phase reactants of the blood in rat adjuvant arthritis as indicators of the degree of inflammation and of “specific” and unspe-cific anti-inflammatory effects. Z Rheumatol 36:305PubMedGoogle Scholar
  63. 63.
    Hischelmann R, Bekemeier H (1982) Antiinflammatory activity of catalase in carageenin edema, manganese chloride edema and adjuvant arthritis of rats. In: Bekemeier H, Hirschelmann R (eds) Pharmacology, Biochemistry and Immunology of the inflammatory reaction. Wiss. Beiträge der Martin-Luther-Universität Halle-Wittenberg, Halle 1982, S 150Google Scholar
  64. 64.
    Invernizzi F, Milazzo E (1963) Importanza delle artriti sperimentali nello studio della pato-genesi dell artrite reumatoide umana. Atti Acad Med Lombarda 18:171Google Scholar
  65. 65.
    Janku J, Perlik F, Seifert J (1980) Lack of correlation between induction of adjuvant arthritis and changes in metabolism and disposition of phenylbutazone in rats. Pharmacology 20:166PubMedCrossRefGoogle Scholar
  66. 66.
    Jessop JD, Currey HLF (1968) Influence of gold salts in adjuvant arthritis in the rat. Ann Rheum Dis 28:577CrossRefGoogle Scholar
  67. 67.
    Kahan A, Kahan A, Amor B, Brouilhet H, Laoussadi S (1985) Nifedipine and hydroxyapatite crystals in adjuvant-induced arthritis in Lewis rats. XVI. Int. Congress of Rheumatology, Sydney, Abstr. Nr. P 487, p 314Google Scholar
  68. 68.
    Kalliomäki JL, Saarimaa HA, Toivanen P (1964) Inhibition by 6 Mercaptopurine of polyarthritis induced by Freund’s adjuvant. Ann Rheum Dis 23:78CrossRefGoogle Scholar
  69. 69.
    Kalliomäki JL, Jalava S, Möttönen M (1974) On the development of adjuvant arthritis in the joint intraarticularly irradiated by radioactive Yttrium-90-Y Resin. Scand J Rheumatol 3:25PubMedCrossRefGoogle Scholar
  70. 70.
    Kapusta MA, Mendelson J (1969) The inhibition of adjuvant disease in rats by the in-terferon-inducing agent pyran-colomer. Arthr Rheum 12:463CrossRefGoogle Scholar
  71. 71.
    Kayashima K, Koga T, Onoue K (1976) Role of T-lymphocytes in adjuvant arthritis. I. Evidence for the regulatory function of thymus derived cells in the induction of the disease. J Immunol 17:1878Google Scholar
  72. 72.
    Keitel W (1967) Untersuchungen bei der Adjuvans-Arthritis der Ratte. Allergie und Asthma 13:91Google Scholar
  73. 73.
    Keitel W, Ziegeler J (1969) Die Adjuvansarthritis der Ratte. III. Untersuchungen zur Pathogenese. Z Rheumaforschg 28:434Google Scholar
  74. 74.
    Kessel JB, Forst MB, Corbin LR et al. (1978) Effect of anthranilic acid on peritoneal fluid cellular content of adjuvant arthritic rats. IRCS Med Sci Cell Memb Biol 6:209Google Scholar
  75. 75.
    Keßler F-W(1985) Thermometrie bei experimentellen Entzündungen: Untersuchungen zum Verhalten der Hauttemperatur bei Rattenpfoten-Ödemen im spontanen Entzündungsverlauf sowie unter einer örtlichen Kühlung. Inaugural-Diss. GießenGoogle Scholar
  76. 76.
    Kienecker B (1974) D-Penicillamin bei der Adjuvansarthritis der Ratte. Med Welt 25:1540PubMedGoogle Scholar
  77. 77.
    Klamer B, Kimura ET, Makstenieks M (1968) Effects of oral cysteine, penicillamine and N acetyl penicillamine on adjuvant arthritis in rats. Pharmacology 1:283PubMedCrossRefGoogle Scholar
  78. 78.
    Kosowska E (1971) The effect of antilymphocyte serum on the cell mediated and humoral immunologie responses in rats. Reumatologia 9:391 (Zit. n. Exc Med Arthritis Rheum 1973)Google Scholar
  79. 79.
    Kourounakis L, Nelson RA Jr, Kapusta MA (1973) The effect of a cobra venom factor on complement and adjuvant-induced disease in rats. Arthritis Rheum 16:71PubMedCrossRefGoogle Scholar
  80. 80.
    Kourounakis L, Kapusta MA (1976) Restoration of diminished T-cell function in adjuvant induced disease by methotrexate: evidence for two populations of splenic T-cell suppressors. Can J Rheumatol 3:346Google Scholar
  81. 81.
    Kozina W, Müller W (1977) Der Einfluß von Nervenläsionen auf den Verlauf der Adjuvans-Arthritis. Z Rheumatol 36:390PubMedGoogle Scholar
  82. 82.
    Kuberasampth Th, Böse SM (1981) Effect of adjuvant induced arthritis on the mechanical properties and thermal behaviour of skin and tendon. Conn Tissue Res 8:93CrossRefGoogle Scholar
  83. 83.
    Kumagai Y, Shiokawa Y, Medsger ThA Jr, Rodnan G (1984) Clinical spectrum of connective tissue disease after cosmetic surgery. Observation on eighteen patients and a review of the Japanese literature. Arthritis Rheum 27:1Google Scholar
  84. 84.
    Kunkel SL, Ogawa H, Conran PB (1981) Suppression of acute and chronic inflammation by orally administered prostaglandins. Arthritis Rheum 24:1151PubMedCrossRefGoogle Scholar
  85. 85.
    Lalive d’Epinay-Zimmerli R (1968) Experimentelle Uveitis in der Ratte nach subkutaner Injektion von Freundschem Adjuvans. Histologische Veränderungen der Uvea. Experientia 155:271Google Scholar
  86. 86.
    Liyanage SP, Currey HLF (1972) Failure of oral D-Penicillamine to modify adjuvant arthritis or immune response in the rat. Ann Rheum Dis 31:521PubMedCrossRefGoogle Scholar
  87. 87.
    Lorenzetti OJ, Fortenberry B, Busby E (1972) Influence of bee venom in the adjuvant induced arthritic rat model. Res Commun Chem Pathol Pharmacol 4:339PubMedGoogle Scholar
  88. 88.
    Lussier A, DeMedicis R, Marquis L, Menard H (1978) Inhibition of adjuvant-induced arthritis in the hyperuricemic rat. Agents Actions 8:536PubMedCrossRefGoogle Scholar
  89. 89.
    Lussier A, DeMedicis R, Mathon G (1978) Inhibition de l’arthrite a adjuvant par l’oxonate: Influence de l’uricemia. Experientia 34:995PubMedCrossRefGoogle Scholar
  90. 90.
    Matsui K, Shichikawa K (1978) Osteoporose corticale du tibia chez le rat atteint d’arthrite adjuvant: Influence de la corticotherapie (Etude radiologique). Rhumatologie 7:263Google Scholar
  91. 91.
    Mellinhoff SM, Pearson CM, Wood FD, Eskelman O, Dixon W (1962) Studies of polyarthritis induced in rats by injection of mycobacterial adjuvant. VI. Effects of dietary alterations. Am J Clin Nutr 10:398Google Scholar
  92. 92.
    Metzke H (1977) Zur Altersabhängigkeit der Adjuvans-Arthritis der Ratte. Allerg Immunol 23:206Google Scholar
  93. 93.
    Michalak E (1973) Mechanism of the action of DL cysteine hydrochloride in delayed type hy-persensitivity. I. Influence of DL cysteine hydrochloride on levels of SH groups in the lymphatic organs of rats with postadjuvant polyarthritis. Arch Immunol Ther Exp (Warsz) 21:249Google Scholar
  94. 94.
    Milanino R, Passarella E, Velo GP (1978) Adjuvant arthritis in young copper-deficient rats. Agents Actions 8:623PubMedCrossRefGoogle Scholar
  95. 95.
    Milhaud G, Labat ML, Moricard Y (1982) Resistance to adjuvant arthritis induced by a genetic mutation, osteopetrosis. Biomed Pharmacother 36:360PubMedGoogle Scholar
  96. 96.
    Mizushima Y, Akaoka I, Nishida Y (1975) Effects of magnetic field on inflammation. Experientia 31:1411PubMedCrossRefGoogle Scholar
  97. 97.
    Miyoshi K, Miyaoka T, Kobayashi Y, Itakura T, Nishijo K, Higashibara M, Shiragamis H, Ohno F (1964) Hypergammaglobulinemia by prolonged adjuvanticity in man: disorders developed after augmentation mammoplasty. Ijishimpo 2122:9Google Scholar
  98. 98.
    Mohr W, Wild A, Beneke G (1974) Chronische Osteomyelitis als Manifestation der Ad-juvans-Krankheit der Ratte. Beitr Pathol 153:1–17PubMedCrossRefGoogle Scholar
  99. 99.
    Mohr W, Wild A, Wolf HP (1980) Untersuchungen zur Pathogenese der entzündlichen Knorpelzerstörung bei der Adjuvans-Arthritis der Ratte. Z Rheumatol 39:212–222PubMedGoogle Scholar
  100. 100.
    Mohr W, Wild A (1976) Morphologische Untersuchungen an Ratten mit langdauernder Ad-juvans-Krankheit. Z Rheumatol 35:301PubMedGoogle Scholar
  101. 101.
    Müller W, Pavelka K, Fridrich R, Meyer-Ruge W (1973) Effects of the intraarticular injections of Yttrium in animal experiments and patients with rheumatoid arthritis. XIII. Int. Congress of Rheumatology, Kyoto, Abstr. 158Google Scholar
  102. 102.
    Müller MN, Kappas A (1964) Estrogen pharmacology. II. Suppression of experimental immune polyarthritis. Proc Soc Exp Biol Med 117:845Google Scholar
  103. 103.
    Narain Sharma J, Nath Sharma J (1977) Comparison of the antiinflammatory activity of Commiphora mukul (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant. Arzneimittelforschg 27:1455Google Scholar
  104. 104.
    Newbould BB (1963) Chemotherapy of arthritis induced in rats by mycobacterial adjuvant. BrJ Pharmacol 21:127Google Scholar
  105. 105.
    Newbould BB (1965) Suppression of adjuvant-induced arthritis in rats with 2-butoxycar-bonyl-methylene-4-oxothiozolidine. Br J Pharmacol 24:632Google Scholar
  106. 106.
    Okana Y, Nishikai M, Sato A (1984) Scleroderma, primary biliary cirrhosis, and Sjögren’s syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann Rheum Dis 43:520CrossRefGoogle Scholar
  107. 107.
    Pearson CM (1956) Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med 91:95PubMedGoogle Scholar
  108. 108.
    Pearson CM (1979) Arthritis in animals. In: McCarty DJ (ed) Arthritis and allied conditions. Philadelphia (9th ed.), p 308Google Scholar
  109. 109.
    Pelczarska A, Gieldanowski J (1970) Treatment of adjuvant arthritis with antibradykinin drugs. J Pharmacol 22:617CrossRefGoogle Scholar
  110. 110.
    Perrine JW, Takesue EI (1968) Use of the rotarod in determining grip strength in rats with adjuvant-induced arthritis. Arch Int Pharmacodyn Ther 174:192PubMedGoogle Scholar
  111. 111.
    Pinals RS (1973) Effect of hepatic injury on adjuvant arthritis. Ann Rheum Dis 32:471PubMedCrossRefGoogle Scholar
  112. 112.
    Possanza GJ, Stewart PW (1970) Suppressant effect of procarbazine and its comparison with antilymphocyte serum in adjuvant induced polyarthritis in rats. Clin Exp Immunol 6:291PubMedGoogle Scholar
  113. 113.
    Quagliata F, Phillips Quagliata JM, Floersheim GL (1972) Immunosuppression by procarbazine. I. Site of action of the drug and effect on adjuvant arthritis and circulating antibody responses. Cell Immunol 3:198Google Scholar
  114. 114.
    Rao CN, Rao VH, Verbruggen L, Orloff S (1980) Effect of bioflavanoids on lysosomal acid hydrolases and lysosomal stability in adjuvant-induced arthritis. Scand J Rheumatol 9:280PubMedCrossRefGoogle Scholar
  115. 115.
    Roba J, Roncucci R, Gillet C, Lambelin G (1975) Etude pharmacologique d’nouvel anti inflammatoire non steroidien, le clopirac. J Belge Rheumatol Med Phys 30 spec. Nr. 3Google Scholar
  116. 116.
    Rooney PJ, Dick WC, Imrie RC, Turner D, Buchanan KD, Ardill J (1978) On the relationship between gastrin, gastric secretion and adjuvant arthritis in rats. Ann Rheum Dis 37:432PubMedCrossRefGoogle Scholar
  117. 117.
    Rosenthale ME, Nagra CL (1967) Comparative effects of some immunosuppressive and anti-inflammatory drugs on allergic encephalomyelitis and adjuvant arthritis. Proc Soc Exp Biol Med 125:149PubMedGoogle Scholar
  118. 118.
    Rovenský J, Grimová J, Pekárek J, Korcáková L (1981) The effects of Thymosin (fraction V) on adjuvant disease in rats. Thymus 3:51PubMedGoogle Scholar
  119. 119.
    Ryzewski J, Ryzewska AG, Brajczewska W (1971) The effect of cysteine on immune response in draining lymph nodes in rats with post adjuvant polyarthritis. Ann Immunol 3:119Google Scholar
  120. 120.
    Saarimaa HA (1964) The anti-inflammatory effect of topically applied phenylbutazone on polyarthritis induced in rats by Freund’s adjuvant. Acta Rheum Scand 10:161PubMedCrossRefGoogle Scholar
  121. 121.
    Schmidt KL, Beneke G (1972) Untersuchungen zur Altersabhängigkeit der Adjuvans-Krank-heit der Ratte. Verh Dtsch Ges Rheumatol 2:110PubMedGoogle Scholar
  122. 122.
    Schmidt KL, Ott VR, Bosmanský K, Pohl J (1972) Biochemische Untersuchungen bei der Adjuvanskrankheit der Ratte. I. Serumenzyme, Mineralien und harnpflichtige Substanzen. Zugleich ein Beitrag zur Altersabhängigkeit von biochemischen Normalwerten bei Laboratoriumstieren. Z Rheumaforsch 31:409Google Scholar
  123. 123.
    Schmidt KL, Ott VR, Baumstieger P (1973) Biochemische Untersuchungen bei der Ad-juvans-Krankheit der Ratte. II. Serumelektrophorese und DNS-Gehalt in Lymphknoten und Milz. Z Rheumaforschg 32:3Google Scholar
  124. 124.
    Schmidt KL, Ott VR (1973) Vergleichbarkeit der Adjuvanskrankheit der Ratte mit Krankheiten des Menschen. Schweiz Med Wochenschr 103:1099PubMedGoogle Scholar
  125. 125.
    Schmidt KL, Jakovlev V (1974) D-Penicillamin bei der Adjuvans-Arthritis der Ratte. Rheumatismus (Darmstadt) 42:130Google Scholar
  126. 126.
    Schmidt KL (1875) Hyperthermie und Fieber — Wirkungen bei Mensch und Tier. Klinik, Pathologie, Immunologie, Wirkungen auf Arthritiden. Hippokrates, StuttgartGoogle Scholar
  127. 127.
    Schmidt KL, Ott VR (1976) Die Wirkung einer „prophylaktischen“ Hyperthermie auf die Adjuvans-Arthritis der Ratte. Z Phys Med 5:47Google Scholar
  128. 128.
    Schmidt KL, Ott VR (1978) Das Verhalten der Körpertemperatur bei der Formalin-und Ad-juvansarthritis der Ratte. Verh Dtsch Ges Rheumatol 4:407Google Scholar
  129. 129.
    Schmidt KL, Ott VR, Röcher G, Schaller H (1979) Heat, cold and inflammation. Z Rheumatol 38:235Google Scholar
  130. 130.
    Schmidt KL, Dettmer J, Mueller-Eckhardt Ch (1983) Körpertemperatur und Immun-Re-aktionen: Die Wirkung einer Ganzkörperhyperthermie auf die Stimulierbarkeit der Lym-phozyten durch Mitogene. Z Phys Med 12:109Google Scholar
  131. 131.
    Schmollack E, Phuoc Le Th, Bekemeier H (1982) Der Einfluß von Phenylbutazon auf den Zinkspiegel des Serums und Pfotengewebes von Ratten mit Adjuvansarthritis. In: Bekemeier H, Hirschelmann R (Hrsg) Pharmacology, Biochemistry and Immunology of the inflammatory reaction. Wiss. Beiträge der Martin-Luther-Universität Halle-Wittenberg, Halle, S 65Google Scholar
  132. 132.
    Seo S, Saeki K (1980) Inhibition of adjuvant arthritis by salbutamol and aminophylline. Eur J Pharmacol 63:267PubMedCrossRefGoogle Scholar
  133. 133.
    Shimizu ML Nakamura H, Motoyoshi S, Yokoyama Y (1975) Pharmacological studies on 1 methyl 5 p toluoylpyrrole 2 acetic acid (Tolmetin), a new antiinflammatory agent, in experimental animals. I. Antiinflammatory, analgesic and antipyretic activity (Jap.) Pharmacometrics 10:293 (Zit. n. Exc Med Arthritis Rheum 12, 1976)Google Scholar
  134. 134.
    Shinoda H, Kojima E, Kanda K, Irikura R (1975) Studies on N benzensulfonyl-beta-alanine-hydrazide (KH 125) in rats. II. Suppressive effect on adjuvant arthritis in the rats (Jap.) Jap J Allergol 24:437 (Zit. n. Exc Med Arthritis Rheum 12, 1976)Google Scholar
  135. 135.
    Siddiqui HH (1965) Effects of Glycyrrhiza glabra and Moschus moschiferus on arthritis induced in rats by mycobacterial adjuvant. J Pharmacol 27:80Google Scholar
  136. 136.
    Sofia RD, Douglas JF (1973) The prophylactic and therapeutic effects of gold sodium thiomalate against adjuvant-induced polyarthritis in rats. Agents Actions 3:335PubMedCrossRefGoogle Scholar
  137. 137.
    Sofia RD, Knobloch LC, Douglas JF (1976) Effect of concurrent administration of aspirin, indomethacin or hydrocortisone with gold sodium thiomalate against adjuvant induced arthritis in the rat. Agents Actions 6:728PubMedCrossRefGoogle Scholar
  138. 138.
    Steffen C, Formanek K, Timpl R (1968) Hemmung der Adjuvans-Arthritis durch Lathyrismus. Z Immun Allergieforschg 128:451Google Scholar
  139. 139.
    Stoerk HC, Bielinski LC, Budzilovich T (1954) Chronic polyarthritis in rats injected with spleen in adjuvants. Am J Pathol 30:616Google Scholar
  140. 140.
    Stulbarg MS, Eisenstein LP, Van Schoote Y, Kilka JP (1967) Effect of exaggerated movement on the development of lesions in adjuvant disease of rats. Arthritis Rheum 10:317Google Scholar
  141. 141.
    Stuyvesant WW, Jolley WR (1967) Anti-inflammatory activity of D-Alpha-tocopherol (Vitamin E) and linoleic acid. Nature 216:585PubMedCrossRefGoogle Scholar
  142. 142.
    Sutton BM, McGusty E, Walz TD, DiMartino MJ (1972) Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexes. J Medic Chem 15:1095Google Scholar
  143. 143.
    Toivanen P, Toivanen A (1964) The effect of E-aminocapronic acid on adjuvant arthritis in the rat. Experientia 20:579PubMedCrossRefGoogle Scholar
  144. 144.
    Toivanen P, Määttää K, Suolanen R, Tykkylänen R (1967) Effect of estron and progesteron on adjuvant arthritis in rats. Med Pharmacol Exp 17:33Google Scholar
  145. 145.
    Tomikawa A, Ohuchi T, Matsui K, Tohtake T, Takachiho K, Kanaya T, Niitsuma T, Itoh H (1985) Phagocytic function in GST-and Auranofm-treated rats with adjuvant arthritis. XVI. Int. Congress of Rheumatology, Sydney, Poster-Abstr., Nr. 272Google Scholar
  146. 146.
    Trabert U, Rosenthal M, Müller W (1976) The effect of levamisole on adjuvant arthritis in the rat. J Rheumatol 3:166Google Scholar
  147. 147.
    Trnavsky Z, Grimova J, Trnavsky K (1974) The effect of sodium salicylate on collagen metabolism in adjuvant arthritis in rats (Tschech.) Fysiat Rheumatol Vestn 52:340 (Zit. Exc Med Arthritis Rheum 1975)Google Scholar
  148. 148.
    Vernon-Roberts B, Garrett JR, Whitehouse MW, Brooks PM, Haynes DR (1984) Influence of rat strains and arthritogen on actions of gold drugs in adjuvant induced polyarthritis. He-berden Society, Abstract Ann Rheum Dis 43:111Google Scholar
  149. 149.
    Walz DT, DiMartino MH, Misher A (1971) Suppression of adjuvant-induced arthritis in the rat by gold sodium aurothiomalate. Ann Rheum Dis 30:303PubMedCrossRefGoogle Scholar
  150. 150.
    Walz TD, DiMartino MJ, Sutton B, Misher A (1972) SK u. F 36914. An agent for oral chrysotherapy. J Pharmacol Exp Ther 181:292PubMedGoogle Scholar
  151. 151.
    Walz DT, DiMartino MJ, Chaknn LW(1976) Antiarthritic properties and unique pharmacologic profile of potential chrysotherapeutic agents: SK u. F 39126. J Pharmacol Exp Ther 197:142PubMedGoogle Scholar
  152. 152.
    Warren J, Sackstedter MR, Thuning CA (1979) Therapeutic effect of prolonged hyperbaric oxygen in adjuvant arthritis of the rat. Arthritis Rheum 22:334PubMedCrossRefGoogle Scholar
  153. 153.
    Weidner A, Becker HC, Mohr W, Schmidt KL (1985) Entzündungen im Urogenitaltrakt bei der Adjuvans-Arthritis der Ratte — ein Analogon zur „Uroarthritis“ beim Mann? Experimentelle Urologie (Ed R Harzmann et al.) Springer S 242Google Scholar
  154. 154.
    Whitehouse MW (1971) Opening remarks. VIL Europ Congress of Rheumatology, Brighton, Session Animal ModelsGoogle Scholar
  155. 155.
    Winder CV, Lembke LA, Stephens MD (1969) Comparative bioassay of drugs in adjuvant-induced arthritis in rats: Flufenamic acid, mefenamic acid and phenylbutazone. Arthritis Rheum 12:472PubMedCrossRefGoogle Scholar
  156. 156.
    Winter CA, Nuss GW (1966) Treatment of adjuvant arthritis in rats with anti-inflammatory drugs. Arthritis Rheum 9:394PubMedCrossRefGoogle Scholar
  157. 157.
    Winter CA, Kling PJ, Tocco DJ, Tanabe K (1979) Analgesic activity of diflunisal (MK-647; 5-(2,4-difluorophenyl)salicylic acid) in rats with hyperalgesia induced by Freund’s adjuvant. J Pharmacol Exp Ther 211:678PubMedGoogle Scholar
  158. 158.
    Wong S (1975) Pharmacology of Tolmetin: 1 methyl 5 p toluolylpyrrole 2 acetic acid. Ex-cerpta Medica (Zit. n. Exc Med Arthritis Rheum 1976)Google Scholar
  159. 159.
    Yiagou M, Hadjipetrou Kourounakis L (1983) Effect of diet on adjuvant-induced disease and mitogenic response of Fisher rats. Int Arch Allerg Appl Immunol 71:374CrossRefGoogle Scholar
  160. 160.
    Zurier RB, Quagliata F (1971) Suppression of adjuvant arthritis by Prostaglandin E1. Arthritis Rheum 14:426Google Scholar
  161. 161.
    Zurier RB, Ballas M (1973) Prostaglandin E1 (PG E1) suppression of adjuvant arthritis, His-topathology. Arthritis Rheum 16:251PubMedCrossRefGoogle Scholar
  162. 162.
    Zurier RB, Mitnick H, Bloomgarden D, Weissmann G (1973) Effect of bee venom on experimental arthritis. Ann rheum Dis 32:466PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1986

Authors and Affiliations

  • Klaus L. Schmidt
    • 1
  1. 1.Klinik für Physikalische Medizin, Balneologie und RheumatologieKlinikum der Justus-Liebig-Universität GießenBad NauheimGermany

Personalised recommendations